Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Infliximab enhances QOL in Crohn's disease

    • 6 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Infliximab enhances QOL in Crohn's disease. Pharmacoecon. Outcomes News 378, 10 (2002).

    Download citation


    • Placebo
    • Inflammatory Bowel Disease
    • Single Dose
    • Infliximab
    • Great Proportion